3797 related articles for article (PubMed ID: 31294382)
1. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
Kaplan GG; Bernstein CN; Coward S; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S6-S16. PubMed ID: 31294381
[TBL] [Abstract][Full Text] [Related]
6. The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs.
Kuenzig ME; Coward S; Targownik LE; Murthy SK; Benchimol EI; Windsor JW; Bernstein CN; Bitton A; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Jogendran R; Meka S; Weinstein J; Jones May T; Jogendran M; Tabatabavakili S; Hazan E; Hu M; Osei JA; Khan R; Wang G; Browne M; Davis T; Goddard Q; Gorospe J; Latos K; Mason K; Kerr J; Balche N; Sklar A; Kaplan GG
J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S23-S34. PubMed ID: 37674493
[TBL] [Abstract][Full Text] [Related]
7. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data.
Long GH; Tatro AR; Oh YS; Reddy SR; Ananthakrishnan AN
Adv Ther; 2019 Nov; 36(11):3079-3095. PubMed ID: 31562607
[TBL] [Abstract][Full Text] [Related]
10. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease: a Canadian burden of illness review.
Rocchi A; Benchimol EI; Bernstein CN; Bitton A; Feagan B; Panaccione R; Glasgow KW; Fernandes A; Ghosh S
Can J Gastroenterol; 2012 Nov; 26(11):811-7. PubMed ID: 23166905
[TBL] [Abstract][Full Text] [Related]
12. Variation in the Care of Children with Inflammatory Bowel Disease Within and Across Canadian Provinces: A Multi-Province Population-Based Cohort Study.
Kuenzig ME; Stukel TA; Carroll MW; Kaplan GG; Otley AR; Singh H; Bitton A; Fung SG; Spruin S; Coward S; Cui Y; Nugent Z; Griffiths AM; Mack DR; Jacobson K; Nguyen GC; Targownik LE; El-Matary W; Bernstein CN; Dummer TJB; Jones JL; Lix LM; Murthy SK; Peña-Sánchez JN; Nasiri S; Benchimol EI;
Clin Epidemiol; 2024; 16():91-108. PubMed ID: 38374886
[TBL] [Abstract][Full Text] [Related]
13. Variation in care of patients with elderly-onset inflammatory bowel disease in Ontario, Canada: A population-based cohort study.
Kuenzig ME; Stukel TA; Kaplan GG; Murthy SK; Nguyen GC; Talarico R; Benchimol EI
J Can Assoc Gastroenterol; 2021 Apr; 4(2):e16-e30. PubMed ID: 33855268
[TBL] [Abstract][Full Text] [Related]
14. The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape.
Murthy SK; Weizman AV; Kuenzig ME; Windsor JW; Kaplan GG; Benchimol EI; Bernstein CN; Bitton A; Coward S; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Sabrie N; Gupta S; Brar G; Khan R; Im JHB; Davis T; Weinstein J; St-Pierre J; Chis R; Meka S; Cheah E; Goddard Q; Gorospe J; Kerr J; Beaudion KD; Patel A; Russo S; Blyth J; Blyth S; Charron-Bishop D; Targownik LE
J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S97-S110. PubMed ID: 37674501
[TBL] [Abstract][Full Text] [Related]
15. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
[TBL] [Abstract][Full Text] [Related]
16. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
[TBL] [Abstract][Full Text] [Related]
17. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
[TBL] [Abstract][Full Text] [Related]
18. The cost of illness analysis of inflammatory bowel disease.
Pakdin M; Zarei L; Bagheri Lankarani K; Ghahramani S
BMC Gastroenterol; 2023 Jan; 23(1):21. PubMed ID: 36658489
[TBL] [Abstract][Full Text] [Related]
19. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
